date,action,name,rate,target
Nov-19-18,Downgrade,Oppenheimer,Outperform to Perform,
Nov-20-18,Reiterated,Monness Crespi & Hardt,Buy,$103 to $64
Nov-20-18,Downgrade,Raymond James,Outperform to Mkt Perform,
